Inside the Canadian Trial: Peter and Ruth's Experience in the Canadian Clinical Trial скачать в хорошем качестве

Inside the Canadian Trial: Peter and Ruth's Experience in the Canadian Clinical Trial

Peter was diagnosed with Parkinson's in 2008-2009. In 2022, he joined a Canadian clinical trial. The goal of the trial was to investigate the effectiveness of combining light therapy (SYMBYX Neuro and PDCare) with exercise, on wellbeing and quality of life in a Parkinson's cohort. 'His quality of life substantially improved. There's just no doubt about that,' shared Ruth, his spouse and caregiver, when discussing Peter's experience throughout the course of the trial. What are your thoughts on Ruth and Peter's story? Comment below. Learn more about the clinical trial here: https://www.mdpi.com/2077-0383/14/21/... *Individual results vary. This testimonial is based on a user's isolated, subjective experience in a SYMBYX-funded clinical trial independently reviewed by external researchers.The PDCare Laser is an ARTG-listed, MDD-compliant medical device intended as a complementary therapy for PD symptom reduction. The SYMBYX Neuro is a general wellness device (not a medical device) for well-being. Consult your qualified healthcare provider for any medical concerns. This content is for informational purposes only.